Radiopharmaceuticals are radioactive substances that are used for diagnosis or therapy purposes. These are made up of two components: a radioactive isotope that can be injected safely into the body, and a carrier molecule that delivers the isotope to the area to be treated or examined. Radiopharmaceuticals set out radiation, mostly in the form of alpha and beta particles, and target the affected areas. The dosages of radiopharmaceuticals that are used to diagnose medical problems vary, depending on the type of diagnosis. When radiopharmaceuticals are injected into the body, they emit radiation that can be traced with special cameras or computers. Radiopharmaceuticals find a major application in the field of oncology. Radiopharmaceuticals used in cancer treatment are small and simple substances, containing a radioactive isotope, and target specific areas of the body where cancer is present.

01. Executive Summary

02. Scope of the Report

02.1 Market Overview

02.2 Product Offerings

03. Market Research Methodology

03.1 Market Research Process

03.2 Research Design

03.3 Research Methodology

04. List of Abbreviations

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Global Radiopharmaceuticals Market Segmentation by

Application

07.1 Global Diagnostic Radiopharmaceuticals Market

07.1.1 Market Size and Forecast

07.2 Global Therapeutics Radiopharmaceuticals Market

07.2.1 Market Size and Forecast

08. Geographical Segmentation

09. Key Leading Countries

09.1 USA

09.2 Germany

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Acquisitions

17.2 Market Share Analysis

17.3 Other Prominent Vendors

18. Key Vendor Analysis

18.1 Cardinal Health Inc.

18.1.1 Business Overview

18.1.2 Business Segmentation

18.1.3 Key Information

18.1.4 SWOT Analysis

18.2 Covidien plc

18.2.1 Business Overview

18.2.2 Business Segmentation

18.2.3 Key Information

18.2.4 SWOT Analysis

18.3 GE Healthcare Ltd.

18.3.1 Business Overview

18.3.2 Key Information

18.3.3 SWOT Analysis

18.4 IBA Molecular Inc.

18.4.1 Business Overview

18.4.2 Business Segmentation

18.4.3 Key Information

18.4.4 SWOT Analysis

18.5 Lantheus Medical Imaging Inc.

18.5.1 Business Overview

18.5.2 Key Information

18.5.3 SWOT Analysis

18.6 Nordion Inc.

18.6.1 Business Overview

18.6.2 Business Segmentation

18.6.3 Key Information

18.6.4 SWOT Analysis

19. Other Reports in this Series